Bio-Rad Laboratories Inc - Company Profile
Powered by
All the data and insights you need on Bio-Rad Laboratories Inc in one report.
- Save hours of research time and resources with
our up-to-date Bio-Rad Laboratories Inc Strategy Report
- Understand Bio-Rad Laboratories Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Bio-Rad Laboratories Inc (Bio-Rad) manufactures and distributes life science research and clinical diagnostics products. The company's product portfolio includes antibodies, autoimmune testing kits, blood typing and antibody detection systems, cell isolation and analysis tools, and digital PCR, among others. The company serves to various markets including life science research, healthcare, analytical chemistry, and other markets. Bio-Rad’s products find applications in bioprocess analytics, cell research, gene expression analysis, immunology, and mutation detection, among others. It markets products through a direct sales force and a network of distributors, agents, brokers, and resellers worldwide. The company operates in the US, Canada, Latin America, Europe and Asia, among others. Bio-Rad Laboratories Inc is headquartered in Hercules, California, the US.
Bio-Rad Laboratories Inc premium industry data and analytics
Products and Services
Products | Services |
---|---|
Life Science Research: | Process Separation: |
Genomics | Ion Exchange Resins |
Next-Generation Sequencing | Mixed-Mode Resins |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In April, the company entered into an agreement with Oncocyte Corporation to create transplant monitoring products using Droplet Digital PCR instruments and reagents. |
2024 | New Products/Services | In April, the company introduced the ddPLEX ESR1 Mutation Detection Kit. |
2024 | New Products/Services | In March, the company introduced CelSelect slides with validated antibodies for rare cell circulating tumor cell enumeration. |
Competitor Comparison
Key Parameters | Bio-Rad Laboratories Inc | F. Hoffmann-La Roche Ltd | Thermo Fisher Scientific Inc | Abbott Laboratories | Danaher Corp |
---|---|---|---|---|---|
Headquarters | United States of America | Switzerland | United States of America | United States of America | United States of America |
City | Hercules | Basel | Waltham | Abbott Park | Washington |
State/Province | California | - | Massachusetts | Illinois | WashingtonD.C. |
No. of Employees | 8,030 | 103,605 | 122,000 | 114,000 | 61,000 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Norman D. Schwartz | Chairman; President; Chief Executive Officer | Executive Board | 2012 | 74 |
Roop K. Lakkaraju | Chief Financial Officer; Executive Vice President | Senior Management | 2024 | - |
Andrew J. Last | Chief Operating Officer; Executive Vice President | Senior Management | 2019 | 64 |
Tania DeVilliers | Senior Director; Interim Principal Accounting Officer; Controller | Senior Management | 2023 | - |
Timothy S. Ernst | Executive Vice President; Secretary; General Counsel | Senior Management | 2016 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer